Breakthrough for Young Patients with a Rare Form of Liver Cancer
Extremely rare liver cancer that mostly affects people in their twenties associated with a gene rearrangement, mostly lethal, until now.
Breakthrough for Young Patients with a Rare Form of Liver Cancer
For Medical Oncology, Déjà Vu All Over Again
Nagourney Cancer Institute: 20-year Experience in 10,000 Patients
Benefits of Combining Functional Profiling with Nagourney Cancer Institute's 11,000 Patient Studies
Cancer Patients Do Not Need to Take No for an Answer
Functional Profiling vs. Functional Medicine: What’s the Difference?
Treatment for Stage 4 Pancreatic Cancer May Be at Hand
A Year-End Reflection
Lung Cancer Patients Need More Than a Lungmap to Nowhere
Is The Role Of The Oncologist To Add Drugs or Subtract Drugs?
Do Rare Tumors Hold The Key To Future Cancer Cures?
Fibrolamellar Cancer Foundation Symposium September 29, 2022